Physician profile
Jonathan Mallen
NPI 1396132478
$2,752.62
in general payments reported to CMS, 2019-2025
12 companies · $633 in 2025
The $633 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,189 · 2022: $325 · 2023: $283 · 2024: $322 · 2025: $633.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,239.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,238.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $618.56 | 2021-2023 | Acclarent Navwire |
| Stryker Corporation | $469.79 | 2021-2025 | Nasopore, Latera, Clarifix |
| Integra Lifesciences Corporation | $403.80 | 2024-2025 | Inspira Air, Acclarent Aera, Relieva Spinplus Nav |
| Glaxosmithkline, LLC. | $374.33 | 2021-2025 | Nucala |
| Optinose US, INC. | $270.36 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $220.49 | 2021-2025 | Dupixent |
| Nobel Biocare USA | $147.63 | 2021 | |
| Genzyme Corporation | $112.59 | 2022-2024 | |
| Aerin Medical INC. | $48.15 | 2025 | |
| Merck Sharp & Dohme LLC | $44.01 | 2021-2023 | |
| Precigen, INC. | $28.66 | 2025 | |
| Medtronic, INC. | $14.25 | 2023 | Sinuva |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Mallen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.